Eclanamine, formerly known as U-48753E, is a potential agent which was subjected to a battery of short-term assays for genetic activity. U-48753E was discovered to be slightly mutagenic in the AS52 assay, and significant efforts were expended in evaluation of the metabolism-based generation of a reactive intermediate. References: Aaron CS, Harbach PR, Mattano SS, Mayo JK, Wang Y, Yu RL, Zimmer DM. Risk and benefit evaluation in development of pharmaceutical products. Environ Health Perspect. 1993 Oct;101 Suppl 3:291-5. Review. PubMed PMID: 8143634; PubMed Central PMCID: PMC1521120.

纯度：≥98%

CAS：67450-45-7